🔬 Diagnostics
We build innovative diagnostic and monitoring tools that empower people to make better decisions about their health.
🧬 Drug Discovery
We translate early-stage research into customized RNAi and CRISPR Cas9 animal and cell models to accelerate drug development.
💊 Therapeutics
We identify and validate new drug targets, unleashing the commercial potential of RNAi to benefit people on a global scale.
Established in 2010 to harness the power of RNAi and genetic engineering technologies developed by our founders in the labs of the world’s leading experts at Cold Spring Harbor Laboratory, Howard Hughes Medical Institute, and Harvard Medical School, Mirimus creates innovative research and clinical technologies to address health issues on a global scale.
Today, Mirimus markets multiple unique and high-value drug discovery and diagnostic products and services, and is advancing a pipeline of therapeutic candidates in partnership with leading biopharma companies to create novel high-impact health care solutions that benefits society on a global scale.
Mirimus’ ability to leverage its cutting-edge science and proprietary technology platforms to rapidly create new, affordable technology and products at scale is core to the way we work. We embrace diversity and creativity and have a proven track record of innovative problem solving—which led to our recognition as a $1M grand prize winner of the XPRIZE competition by developing a radically affordable, rapid, non-invasive methodology for mass COVID-19 testing—driving us to make better drugs and detect disease earlier.
At Mirimus, our ingenuity, respect for our colleagues’ ideas and creativity, executional agility, and a commitment to global health equity combine to create a unique culture of innovation that delivers measurable progress.
Company Details
- Employees
- 62
- Founded
- -
- Address
- 760 Parkside Ave, Brooklyn,new York 11226,united States
- Phone
- 516) 882-7111
- in****@****mus.com
- Industry
- Biotechnology
- Website
- mirimus.com
- Keywords
- Transgenic mice, RNA interference, Drug discovery tools, shRNA technology, COVID-19, CRISPR, Pool Testing.
- HQ
- Brooklyn, New York
Mirimus Questions
Mirimus's helpline number is 516) 882-7111
Mirimus's website is mirimus.com
Mirimus's LinkedIn profile is https://www.linkedin.com/company/mirimus
Mirimus has
62 employees.
View email and phone details for 62
employees at Mirimus.
Mirimus's industry is
Biotechnology
Mirimus's top competitors are
Helaina,
Eikon Therapeutics,
Rumi Scientific,
Synthis Therapeutics, Inc.,
Anvesana,
Immunai,
Regeneron,
Lime Therapeutics,
Micoy Therapeutics,
Newyorkbio.
Mirimus's support email address is info@mirimus.com
Mirimus's categories are Biotechnology
Mirimus's founding year is 2010
